Nutrient transporters: connecting cancer metabolism to therapeutic opportunities

Area of Science:

• Oncology
• Molecular Biology
• Cellular Metabolism

Background:

• Cancer cells require specific extracellular nutrients for growth and metabolism.
• Solute carrier (SLC) transporters are crucial for nutrient uptake and intracellular transport.
• The roles of many SLC transporters in cancer progression remain largely uncharacterized.

Purpose of the Study:

• To summarize current knowledge and identify gaps regarding SLC transporters in cancer.
• To highlight therapeutic opportunities by targeting SLC transporters.
• To explore strategies for overcoming cancer cell resistance to transporter-targeted therapies.

Main Methods:

• Literature review of recent findings on SLC transporters in cancer.
• Analysis of existing inhibitors for SLC transporter research.
• Examination of clinical trials targeting transporters in cancer therapy.
• Investigation of compensatory mechanisms in cancer cells.

Main Results:

• Numerous SLC transporters play significant roles in cancer cell metabolism and growth.
• Existing inhibitors and ongoing clinical trials show promise for transporter-targeted cancer therapy.
• Cancer cells can develop compensatory transporter activity to evade treatment.
• Specific SLC transporters are implicated in acquired resistance to cancer therapies.

Conclusions:

• Targeting SLC transporters presents a promising avenue for novel cancer therapies.
• Simultaneous or combination targeting of transporters may enhance treatment efficacy.
• Understanding compensatory mechanisms is key to developing durable therapeutic strategies.
• Further research into SLC transporter functions in cancer is warranted.